Clinical Trials Logo

Scapholunate Advanced Collapse clinical trials

View clinical trials related to Scapholunate Advanced Collapse.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04580225 Recruiting - Arthritis Clinical Trials

Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE)

PARTE
Start date: January 7, 2021
Phase: N/A
Study type: Interventional

This randomized clinical trial (RCT) aims to compare clinical and radiographic outcomes of different partial wrist fusion techniques in participants with post-traumatic wrist arthritis. Participants with stage II or III scapholunate advanced collapse (SLAC) or scaphoid nonunion advanced collapse (SNAC) who meet the eligibility criteria will be randomly assigned to one of two parallel groups: Group A (partial wrist arthrodesis without triquetral excision i.e. four-corner arthrodesis), or Group B (partial wrist arthrodesis with triquetral excision i.e. three-corner or capitolunate arthrodesis with triquetral excision). The results of this study will provide evidence to guide surgeons in determining the ideal wrist fusion technique in the management of patients with post-traumatic wrist arthritis requiring surgery.

NCT ID: NCT04260165 Recruiting - Clinical trials for Wrist Osteoarthritis

Proximal Row Carpectomy vs Four-corner Fusion for Osteoarthritis of the Wrist

PROOF
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Study purpose is to compare the outcome after proximal row carpectomy (PRC) vs four-corner fusion (FCA) for SLAC/SNAC II-III type osteoarthritis (OA) in a double-blinded randomized controlled study setting. Patients with radiologically and clinically confirmed OA are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo either PRC or FCA. The study will be patient and assessor blinded. Baseline data is collected preoperatively and is followed by a follow-up visits at 2 and 6 weeks, 3, 6, 12 months, and 5, 10 years after the intervention. Unveiling of the allocation is at 12 months post-intervention.